Published in Oral Microbiol Immunol on April 01, 2003
The roles of antimicrobial peptides in innate host defense. Curr Pharm Des (2009) 1.58
Antiviral mechanisms of human defensins. J Mol Biol (2013) 1.22
Antimicrobial peptides in human skin disease. Eur J Dermatol (2007) 1.17
Human beta-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells. Antimicrob Agents Chemother (2006) 1.03
Beta-defensins: what are they really doing in the oral cavity? Oral Dis (2011) 0.99
Scientific frontiers: emerging technologies for salivary diagnostics. Adv Dent Res (2011) 0.99
Collectins and cationic antimicrobial peptides of the respiratory epithelia. Vet Pathol (2006) 0.97
Human alpha- and beta-defensins bind to immobilized adhesins from Porphyromonas gingivalis. Infect Immun (2008) 0.95
Defensins as anti-inflammatory compounds and mucosal adjuvants. Future Microbiol (2010) 0.95
CXC chemokines and antimicrobial peptides in rhinovirus-induced experimental asthma exacerbations. Clin Exp Allergy (2014) 0.94
The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation. Skin Pharmacol Physiol (2012) 0.93
Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity. Periodontol 2000 (2010) 0.92
Differential and coordinated expression of defensins and cytokines by gingival epithelial cells and dendritic cells in response to oral bacteria. BMC Immunol (2010) 0.88
The yin and yang of human Beta-defensins in health and disease. Front Immunol (2012) 0.88
Defensins attenuate cytokine responses yet enhance antibody responses to Porphyromonas gingivalis adhesins in mice. Future Microbiol (2010) 0.83
Polymorphism of DEFA in Chinese Han population with IgA nephropathy. Hum Genet (2014) 0.82
Differential expression pattern of genes encoding for anti-microbial peptides in the fetal membranes of patients with spontaneous preterm labor and intact membranes and those with preterm prelabor rupture of the membranes. J Matern Fetal Neonatal Med (2009) 0.82
Functions of Cationic Host Defense Peptides in Immunity. Pharmaceuticals (Basel) (2016) 0.77
Innate endogenous adjuvants prime to desirable immune responses via mucosal routes. Protein Cell (2014) 0.75
The Effect of Nonsurgical Periodontal Therapy on HNP1-3 Level in Gingival Crevicular Fluid of Chronic Periodontitis Patients. Arch Immunol Ther Exp (Warsz) (2017) 0.75
Large scale isolation of functionally active components of the human complement system. J Biol Chem (1981) 5.26
Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci U S A (1998) 3.85
Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest (1998) 3.78
Tritium labeling of proteins to high specific radioactivity by reduction methylation. J Biol Chem (1980) 3.04
Evidence for presence of an internal thiolester bond in third component of human complement. Proc Natl Acad Sci U S A (1980) 3.00
Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol (2000) 2.55
Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J Biol Chem (2001) 2.50
A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest (1995) 2.48
The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeats. Cell (1986) 2.36
Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun (2000) 2.24
Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun (1999) 2.19
Altered fluid transport across airway epithelium in cystic fibrosis. Science (1993) 2.09
Discovery of new human beta-defensins using a genomics-based approach. Gene (2001) 2.08
Cloning, expression, and tissue distribution of a human amiloride-sensitive Na+ channel. Am J Physiol (1994) 2.07
Metabolism of gallic acid and syringic acid by Pseudomonas putida. J Biol Chem (1972) 2.04
Purification and properties of 4-hydroxy-4-methyl-2-oxoglutarate aldolase. J Biol Chem (1972) 2.04
Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia. Hum Gene Ther (1998) 2.00
Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation. Gene (1998) 1.99
Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production. Gene Ther (2005) 1.93
Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes. J Exp Med (1977) 1.79
Amino-terminal sequence of p36 and associated p10: identification of the site of tyrosine phosphorylation and homology with S-100. Proc Natl Acad Sci U S A (1985) 1.72
Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. Am J Respir Crit Care Med (1995) 1.70
Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc Natl Acad Sci U S A (1987) 1.68
Third component of human complement: appearance of a sulfhydryl group following chemical or enzymatic inactivation. Biochemistry (1980) 1.67
The role of surveillance endoscopic retrograde cholangiopancreatography in preventing episodic cholangitis in patients with recurrent common bile duct stones. Endoscopy (1998) 1.64
Idiopathic recurrent pancreatitis. An approach to diagnosis and treatment. Dig Dis Sci (1989) 1.58
Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer. J Immunol (1981) 1.55
Disruption of the beta subunit of the epithelial Na+ channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype. Proc Natl Acad Sci U S A (1999) 1.53
Transient surfactant protein B deficiency in a term infant with severe respiratory failure. J Pediatr (1998) 1.53
Structural analysis of human complement protein H: homology with C4b binding protein, beta 2-glycoprotein I, and the Ba fragment of B2. J Immunol (1986) 1.53
Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol (2001) 1.52
Fifth component of human complement: purification from plasma and polypeptide chain structure. Biochemistry (1979) 1.49
Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry (1985) 1.49
Pressure measurements from biliary and pancreatic segments of sphincter of Oddi. Comparison between patients with functional abdominal pain, biliary, or pancreatic disease. Dig Dis Sci (1991) 1.48
Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J Clin Invest (1999) 1.46
Influence of cell polarity on retrovirus-mediated gene transfer to differentiated human airway epithelia. J Virol (1998) 1.46
Endoscopic treatment of problems encountered after laparoscopic cholecystectomy [corrected]. Gastrointest Endosc (1993) 1.45
Third component of human complement: structural analysis of the polypeptide chains of C3 and C3b. Biochemistry (1979) 1.44
Integrase-defective lentiviral vectors: progress and applications. Gene Ther (2009) 1.41
Third component of human complement: structural requirements for its function. Biochemistry (1980) 1.38
Murine protein H is comprised of 20 repeating units, 61 amino acids in length. Proc Natl Acad Sci U S A (1986) 1.37
Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J Periodontol (2001) 1.35
Nucleotide sequence of complementary DNA and derived amino acid sequence of murine complement protein C3. Philos Trans R Soc Lond B Biol Sci (1984) 1.29
Primary structure of bovine calpactin I heavy chain (p36), a major cellular substrate for retroviral protein-tyrosine kinases: homology with the human phospholipase A2 inhibitor lipocortin. Biochemistry (1986) 1.28
Orientation and dynamics of an antimicrobial peptide in the lipid bilayer by solid-state NMR spectroscopy. Biophys J (2001) 1.27
A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus. Hum Mol Genet (1993) 1.22
The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrob Agents Chemother (2001) 1.22
Third component of human complement: localization of the internal thiolester bond. Proc Natl Acad Sci U S A (1982) 1.20
Sequence determination of the thiolester site of the fourth component of human complement. Proc Natl Acad Sci U S A (1981) 1.19
Increasing epithelial junction permeability enhances gene transfer to airway epithelia In vivo. Am J Respir Cell Mol Biol (2000) 1.18
The beta-Cys-gamma-Glu thiolester bond in human C3, C4, and alpha 2-macroglobulin. Springer Semin Immunopathol (1983) 1.18
Early-onset inflammatory responses in vivo to adenoviral vectors in the presence or absence of lipopolysaccharide-induced inflammation. Am J Respir Cell Mol Biol (1999) 1.17
Human coronavirus 229E infects polarized airway epithelia from the apical surface. J Virol (2000) 1.17
Binding of C3b proceeds by a transesterification reaction at the thiolester site. Nature (1982) 1.17
Fourth component of human complement: studies of an amine-sensitive site comprised of a thiol component. Biochemistry (1981) 1.17
Primary structure of the fifth component of murine complement. Biochemistry (1987) 1.16
Chronic liver disease and acetaminophen. Ann Intern Med (1977) 1.16
Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells. Antimicrob Agents Chemother (2001) 1.14
A novel murine beta -defensin expressed in tongue, esophagus, and trachea. J Biol Chem (2000) 1.14
Prostaglandin E (PGE) and interleukin-1 beta (IL-1 beta) levels in gingival crevicular fluid during human orthodontic tooth movement. Am J Orthod Dentofacial Orthop (1994) 1.13
Effect of glutathione peroxidase activity on lipid peroxidation in biological membranes. Biochim Biophys Acta (1976) 1.12
Treatment of pancreatic pseudocysts with ductal communication by transpapillary pancreatic duct endoprosthesis. Gastrointest Endosc (1995) 1.12
A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy. J Periodontal Res (2009) 1.12
Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother (2001) 1.10
Infection of human airway epithelia with H1N1, H2N2, and H3N2 influenza A virus strains. Mol Ther (2001) 1.09
Localization of epithelial sodium channel subunit mRNAs in adult rat lung by in situ hybridization. Am J Physiol (1996) 1.09
The effect of smoking on the response to periodontal therapy. J Clin Periodontol (1994) 1.07
Antigen-specific B-cell unresponsiveness induced by chronic Mycobacterium avium subsp. paratuberculosis infection of cattle. Infect Immun (1999) 1.07
Susceptibilities of oral bacteria and yeast to mammalian cathelicidins. Antimicrob Agents Chemother (2001) 1.06
NH2-terminal structure and cleavage of guinea pig pro-C3, the precursor of the third complement component. J Biol Chem (1981) 1.05
The superfamily of C3b/C4b-binding proteins. Fed Proc (1987) 1.04
Gallinacin-3, an inducible epithelial beta-defensin in the chicken. Infect Immun (2001) 1.03
In vitro cytotoxicity of a new epoxy resin root canal sealer. J Endod (2000) 1.03
Structure of murine complement component C3. I. Nucleotide sequence of cloned complementary and genomic DNA coding for the beta chain. J Biol Chem (1984) 1.02
Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiol Immunol (2009) 1.02
Levels of cigarette consumption and response to periodontal therapy. J Periodontol (1996) 1.02
The piglet as a model for B cell and immune system development. Vet Immunol Immunopathol (2008) 1.02
Structure of murine complement component C3. II. Nucleotide sequence of cloned complementary DNA coding for the alpha chain. J Biol Chem (1984) 1.01